Oracle (ORCL) stock performance has been modest with a 10% decline over the past 52 weeks. While valuations look attractive, markets are concerned about AI investments, balance sheet impact, and cash flows.
However, even after allaying these concerns, Oppenheimer raised ORCL stock to “Outperform” from “Perform” with a $185 price target. The upside thesis is supported by the view that Oracle is likely to be a strong EPS mix. Even after a 25% haircut to management’s guidance, Oracle’s EPS is likely to double by 2030. Additionally, with Oracle announcing a $40 billion to $50 billion equity and debt financing program for 2026, financing and execution risk will be reduced.
Finally, Oracle’s multiples “have more than halved since September,” per Looking for an alpha. This provides a good opportunity to get into the stock which also offers an annual dividend yield of 1.38%.
Headquartered in Austin, Texas, Oracle provides products and services for IT companies worldwide. The company’s core business segments include cloud, software, hardware, and services. In the first six months of fiscal 2026, the cloud and software segment accounted for 86% of total revenue.
For fiscal 2025, Oracle reported revenue of $57 billion. The company has guided for an impressive revenue target of $225 billion by 2030. This would imply a compound annual growth rate (CAGR) of 31% between FY 2025 and FY 2030. Additionally, for the same period, Oracle expects non-GAAP EPS to grow at a CAGR of $2820 to 2020.
While Oracle has lofty growth goals, ORCL stock has corrected by 34% over the past six months. This is a good accrual opportunity as the company is focused on executing its remaining performance obligations (RPO) which have reached $523 billion by Q2 of FY2026.
Oracle is witnessing rapid growth in RPO with commitments from the likes of OpenAI, Meta Platforms ( META ), and Nvidia ( NVDA ), among others. However, the stock price is at a low level.
An important reason is the market’s skepticism about financing and execution. However, Oracle took a positive step by raising $25 billion in debt in February 2026 — a record-setting bond deal that eased funding concerns. Notably, Oracle has also entered into an equity distribution deal to sell up to $20 billion of stock. With a cash buffer of $19.2 billion through Q2 2026, funding growth is unlikely to be a concern.






